IPHA Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own IPHA shares is N/A, representing N/A of the company's common stock.

MORGAN STANLEY, in the last quarter, reduced its stake in IPHA by -4.81% restricting it's holding to 44.12 thousand shares of worth nearly $127.08K. MILLENNIUM MANAGEMENT LLC also lessened -11.86% of the IPHA shares from its portfolio, reducing its holding to 10.58 thousand shares of worth $30.47K. OPTIVER HOLDING B.V. also shunned IPHA shares holding by -88.06% last quarter which brought its holding to 22.71 thousand shares worth $63.57K.

As per its latest 13F filing, UBS GROUP AG increased its stake in IPHA by 43.84% in the last quarter. The institutional holder raised its holding to 210 shares having worth more than $604.00. JANE STREET GROUP, LLC also added 100% more shares of IPHA to its portfolio, raising its holding to 14.55 thousand shares of worth $41.92K. EXCHANGE TRADED CONCEPTS, LLC also increased its IPHA shares holding by 141.15% which brought its holding to 113.07 thousand shares worth $325.64K.

The insider with the most stakes in IPHA is N/A , N/A at the company. Additionally, IPHA stock is highly held by N/A N/A and N/A N/A among others.

Company executives, directors, and other insiders own N/A percent of Innate Pharma S.A.'s stock. Within the last six months, there have been 0 transaction(s) in which IPHA insiders have sold stock, totaling 0 shares. Insiders that have sold shares include .

There have been 0 transaction(s) during the past 6-months in which Innate Pharma S.A. insiders have bought stock, totalling 0 shares

Around 0 Innate Pharma S.A. shares are held by insiders, which represents about N/A of IPHA stock.

IPHA N/A, N/A holds the largest portfolio of the company's shares. IPHA shares owned by N/A total nearly -.

UBS GROUP AG is the largest institutional owner in IPHA which holds 210 shares worth $604.00 or 0% of the total IPHA shares outstanding followed by RHUMBLINE ADVISERS with ownership of 205 shares representing 0% of the IPHA ownership. MORGAN STANLEY is the third largest stakeholder with 44.12 thousand shares or 0.05% of the ownership worth more than $127.08K.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the IPHA is concerned, it is a stock which is not optionable.

Number of IPHA shares short is 152.46K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 83.81M shares of IPHA are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, IPHA has 31.56M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for IPHA is 3.06.